Form 4: Bristol-Myers Squibb SVP and Controller, Phil M. Holzer, Reports Stock Sale

Sentiment:

SEC Form 4 Filing


Phil M. Holzer, SVP and Controller at Bristol-Myers Squibb, reported the sale of 700 shares of common stock on November 4, 2024.

Summary

  • On November 4, 2024, Phil M. Holzer, the SVP and Controller of Bristol-Myers Squibb, sold 700 shares of the company's common stock.
  • The sale was executed at a price of $55.615 per share.
  • Following the transaction, Holzer directly owns 11,760 shares of Bristol-Myers Squibb common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. It is difficult to determine the context of the sale without more information.

Stakeholder Impact

  • The sale of shares by an insider could be perceived negatively by some shareholders, but the relatively small number of shares sold is unlikely to have a significant impact.

Key Dates

DateDescription
11/04/2024Date of stock sale transaction
11/05/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.